ARTICLE | Clinical News
Ushercell: Began Phase I testing
May 10, 1999 7:00 AM UTC
Polydex Pharmaceuticals Ltd. (POLXF), Toronto, Ontario Product: Ushercell Business: Infectious diseases, Reproductive Therapeutic category: Viral infection Target: Viral lipid coats and the acrosome c...